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Knowledge of the molecular events regulating the innate response to Mycobacterium tuberculosis (Mtb) is critical for understanding
immunological pathogenesis and protection from tuberculosis. To this aim, the regulation and the expression of regulatory and
proinflammatory cytokines were investigated in human primary monocytes upon Mtb infection. We found that Mtb-infected
monocytes preferentially express a proinflammatory cytokine profile, including IL-6, TNF-α, and IL-1β. Conversely, among the
regulatory cytokines, Mtb elicited IL-10 and IL-23 release while no expression of IL-12p70, IL-27, and IFN-β was observed. The
analysis of the signalling pathways leading to this selective cytokine expression showed that in monocytes Mtb activates MAPK and
NF-κB but is unable to stimulate IRF-3 phosphorylation, a transcription factor required for IL-12p35 and IFN-β gene expression.
Thus, by inducing a specific cytokine profile, Mtb can influence the immunoregulatory properties of monocytes, which represent
important target of novel vaccinal strategies against Mtb infection.
1. Introduction
Mortality and morbidity caused by the pulmonary pathogen
Mycobacterium tuberculosis (Mtb) remain alarmingly high
[1]. Although much is known about the immunology
of tuberculosis (TB), the precise nature of the protective
immune mechanisms against Mtb has not been completely
defined. Indeed, it has been estimated that 30% of the
exposed individuals will become tuberculin-positive patients
and, among the infected individuals, only 5%–10% will
develop clinical manifestations of active TB, while the major-
ity controls the infection but not completely eradicates the
bacteria developing into a latent TB [2]. Therefore, the char-
acterization and comprehension of the immune mechanisms
leading to the control of initial infection and to the preven-
tion of reactivation of latent infection are crucial to contain
this disease. A complex series of interactions among various
cell populations is involved in the containment of Mtb infec-
tion [2]. In particular, macrophages and dendritic cells (DCs)
are essential players against Mtb given their involvement
in phagocytosis, antigen processing and presentation, and
cytokine production [3, 4]. After the interaction with Mtb
in the alveoli, macrophages and DC become activated and
participate to the immune response against Mtb infection
playing different roles [5]. DCs are engaged in inducing T
cells in virtue of their production of Th1/IFN-γ-inducing
cytokines and expression of costimulatory molecules, while
macrophages are primarily involved in the formation of the
granuloma, where tissue macrophages harboring tubercle
bacilli are surrounded by and interact with natural killer
(NK) and effector T lymphocytes. Indeed, NK and T cells are
recruited after Mtb infection and produce IFN-γ and TNF-α,
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which play a central role in the host defense against Mtb
given their capacity to activate antimicrobial mechanisms
in monocytes and macrophages [6]. Besides macrophages
and DC, circulating monocytes are increasingly implicated in
defense against a range of microbial pathogens by supplying
tissues with macrophage and DC precursors [7]. We have
identified new mechanisms of Mtb immune evasion that
relies on the capacity of Mtb to interfere with monocyte
differentiation into DC [8, 9]. In particular, our studies
provided evidences that CR3 engagement on monocytes by
mycobacteria leads to p38 mitogen-activated protein kinase
(MAPK) and ATF-2 phosphorylation and that antibody-
dependent CR3 blockade or treatment with a specific p38
MAPK inhibitor caused a notable increase in CD1 molecule
expression in DC derived from mycobacteria-infected cells
[9]. In addition, more recently the involvement of p38
MAPK and Signal Transducer and Activator of transcription
pathways has been described in the expression of Interleukin-
10 (IL-10), which inhibits the differentiation of bystander
noninfected monocytes into DC [8]. Thus, by limiting the
generation of functionally active DC, Mtb could block the
expansion of T lymphocytes lacking effector function and, in
turn, reducing the T cell help provided to infected alveolar
macrophages for killing the intracellular pathogens.
To further investigate the response of monocyte to Mtb
infection, we sought to investigate the profile of proin-
flammatory and regulatory cytokines and the molecular
mechanisms underlying this expression. Our results indicate
that human monocytes produce preferentially proinflam-
matory cytokine profile, including IL-6, TNF-α, IL-1β.
Interestingly, we found that although monocytes activated
IFN regulatory factor (IRF)-3 and synthesized IFN-β in
response to LPS, they failed to do this upon Mtb challenge.
Accordingly, the IFN-β-mediated expression of IL-27p28
did not occur in Mtb-infected monocytes as well as the
release IL-12p70, a cytokine partially dependent on IRF-
3 activation. Conversely, the robust production of IL-23,
another IL-12 family member, was regulated by MAPK
pathway. Collectively, our results highlight the capacity of
Mtb to stimulate in monocytes a specific cytokine profile
whose regulation was mainly dependent on MAPK and NF-
κB signalling.
2. Materials and Methods
2.1. Reagents. LPS from Escherichia coli 0111:B4 (Sigma-
Aldrich, St. Louis, MO, USA) was used at 1 μg/ml. The p38
MAPK inhibitor SB203580 and the ERK inhibitor PD98059
(Calbiochem Biochemicals, San Diego, CA, USA), at an
optimal concentration of 3 μM, were added 30 min before
Mtb infection.
2.2. Bacterial Strains, Media, and Growth Conditions. Mtb
H37Rv (ATCC 27294) was grown and prepared as previously
described [5]. Mtb was harvested at midlogarithmic growth
phase. Bacterial viability was determined by counting the
number of colony-forming units (CFUs) on Middlebrook
7H10 agar plates. All bacteria preparations were analyzed for
LPS contamination by the Lymulus lysate assay (BioWhit-
taker, Verviers, Belgium) and contained less than 1 EU/ml.
2.3. Monocyte Preparation and Infection. Monocytes were
prepared as previously described [5]. Monocytes were cul-
tured at 1× 106 cells/ml in RPMI 1640 (BioWhittaker) sup-
plemented with 2 mM L-glutamine and 15% FCS (BioWhit-
taker). No antibiotics were added to the cultures. Monocytes
were infected with a multiplicity of infection (MOI) of one
bacterium/cell, which was previously found to be optimal
for the infection of primary cells [5]. Mtb preparations
were sonicated prior to infection of monocyte cultures. The
infection was evaluated at various time points (0, 4, and
24 hr) by CFU assay to determine the number of intracellular
bacteria, as previously described [10]. Briefly, 2 hr after
infection, the cell cultures were gently washed (three times)
with RPMI 1640 and centrifuged at 150× g for 10 min to
selectively spin down cells while extracellular bacteria remain
in the supernatants. Cells were resuspended in complete
medium and cultured for the times indicated. T0 refers to
cell cultures washed after 2 hr of infection, where a 20%
reduction of the original MOI was observed. However, we
found that Mtb was able to infect and to survive inside the
monocytes as the number of CFU remained constant over a
24-hr period of examination (data not shown).
2.4. Cytokine Determinations. Supernatants from monocyte
cultures were harvested 24 hr after infection or treatments,
filtered by 0.2 μm low protein-binding syringe filters (Millex-
GV, Millipore, Bedford, MA, USA), and stored at −80◦C.
IL-6, IL-10, IL-12 p70, TNF-α, and IL-1β were measured
with the human inflammation cytometric bead assay (CBA)
(BD Bioscience, Pharmingen, San Diego, CA, USA). The
sensitivity of this assay varies from 1.9 pg/ml for IL-12p70
to 7.2 pg/ml for IL-1β. IL-23 was assayed with ELISA kit
(Bender MedSydtem, Burlingame, CA, USA). The sensitivity
is 20 pg/ml for IL-23. All assays were conducted according to
manufacturers’ instructions.
2.5. RNA Isolation and Real-Time PCR Quantification. RNA
was extracted from DC with RNeasy kit (Qiagen Inc., Valen-
cia, CA, USA) according to the manufacturer’s instructions.
A phenol/chloroform extraction was performed to inactivate
residual mycobacterial particles. Reverse transcriptions were
performed as previously described [11]. Quantitative PCR
assays were performed in triplicate using the Platinum Taq
DNA Polymerase (Invitrogen Life Technologies Frederick,
MD) and the SYBR Green I (BioWittaker Molecular Appli-
cations, Rockland, ME) on a LightCycler (Roche Diag-
nostics, Basel, CH). The sequences of primer pairs have
been previously described [12, 13]. A calibration curve
of a purified positive control RT-PCR product, to whom
arbitrary values were assigned, was used to calculate the
value of a target gene. The quantification standard curves
were obtained using dilutions (4-log range) of the purified
positive control RT-PCR product in 10 μg/ml sonicated
salmon sperm DNA. Quantification data are presented as a
ratio to the GAPDH mRNA level present in the same sample






























































































Figure 1: Cytokine production in Mtb-infected or LPS-treated human monocytes. Monocytes were infected with Mtb (MOI = 1) or treated
with LPS (1 μg/ml). After 24 hr cell culture supernatants were collected and determination of cytokine content was performed by CBA or
ELISA. The results represent the mean± SE of four separate experiments performed with different donors.
and represent the mean± SE of triplicate values. Only ratios
with a SE 0.2 log (95% confidence limits) were considered for
the determination of induction levels. The standard errors
(95% confidence limits) were calculated using the Student’s
t-test.
2.6. Western Blot Analysis. Western blot was performed
as previously described [13]. Briefly, 30 μg of total cell
extracts were separated by SDS-PAGE gel and blotted onto
nitrocellulose membranes. Blots were incubated with 1 μg/ml
of rabbit polyclonal antibodies against IRF-3 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and reacted with anti-
rabbit HRP-coupled secondary antibody (dilution 1 : 2000;
Amersham Pharmacia Biotech, Little Chalfont, UK) using
an ECL system. Western blots were performed on 7% SDS-
PAGE gel to detect the slower migrating phosphorylated
form (IRF-3P), while the IRF-3 content was evaluated in a
shorter run on 10% SDS gels.
2.7. Electrophoretic Mobility Shift Assay (EMSA). Synthetic
double-stranded oligonucleotides were end labeled with [γ-
32P]ATP by T4 polynucleotide kinase. Binding reactions
mixture (20 μl final volume) contained labeled oligonu-
cleotide probes (30,000 cpm) in binding buffer (4% glycerol,
1 mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl,
10 M Tris-HCl (pH 7.5), and 1 μg poly (dI)-poly(dC)).
Nuclear lysates (5 μg) were added, and the reaction mixture
was incubated for 30 min at room temperature. For super-
shift analysis, 1 μg of anti-p65 (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) was added to the reaction. Glycerol
was added to 13% (v/v), and samples were analyzed on
5% polyacrylamide gels with 0.5x TBE (1x TBE is 50 mM
Tris-borate (pH 8.2) and 1 mM EDTA) for 1.5 hr at 200 V
at 18◦C. The oligonucleotide used to monitor the NF-κB
binding to κB sequences within the IFN-β promoter was 5′-
AGTGGGAAATTCCTCT-3′.
2.8. Statistical Analysis. Statistical analysis was performed by
a two-tailed Student t-test for paired data using Java Applets
& Servlets for Biostatistics. A P-value <.05 was considered
statistically significant.






























Figure 2: Expression of IL-27 subunits in Mtb-infected or LPS-treated human monocytes. RNA was extracted from monocytes infected
with Mtb (MOI= 1) or LPS (1 μg/ml) for 8 hr. Real-time reverse transcription-polymerase chain reaction was performed to measure the
expression of IL-27p28 and EBI3 subunits. The results are shown as a ratio to the GAPDH level and represent the mean± SE of triplicate
values. The results shown are from one out of three experiments performed with different donors that yielded similar results.
3. Results and Discussion
3.1. Proinflammatory and Regulatory Cytokine Release from
Mtb-Infected Monocytes. Given the importance of cytokines
in orchestrating the immune response against Mtb [3], we
sought to investigate how Mtb stimulates the expression
profile of proinflammatory and regulatory cytokines in
human primary monocytes, whose role in the immune
response against pathogens is critical in supporting the
development of tissue macrophages and resident DC. To this
aim, supernatants were harvested from monocyte cultures
infected for 24 hr with Mtb (MOI 1 : 1), and the release
of proinflammatory and regulatory cytokines was analyzed
(Figure 1). As control, the cultures were stimulated for 24 hr
with LPS (1 μg/ml). Monocytes responded to Mtb or LPS
stimulation by producing IL-6, TNF-α, and IL-1β and the
regulatory cytokines IL-10 and IL-23, although at different
extent. Conversely, the weak secretion of IL-12p70 from LPS-
treated monocytes was absent in monocyte cultures infected
with Mtb. These results indicated that Mtb differentially
induces the release of IL-12p70 and IL-23 by infected
monocytes and, in turn, modulates the T cell-dependent
inflammatory responses by acting on the balance between
Th1 and Th17 cells [14]. Interestingly, our observations are
in line with recent findings showing the involvement of IL-
23 in mediating protection against intracellular pathogens
[15, 16].
3.2. Expression and Regulation of IL-12 Family Members in
Mtb-Infected Monocytes. To further investigate the expres-
sion of IL-12 family member in Mtb-infected monocytes,
we extended our analysis to another member of IL-12
family, such as IL-27, a heterodimeric protein composed
of IL-27p28 and EBI3 [17]. To this aim, total RNA was
extracted 8 hr after Mtb infection or LPS treatment, and the
transcripts for EBI3 and IL-27p28 subunits were evaluated
by real-time RT-PCR (Figure 2). The data showed that
LPS induced the transcription of both IL-27 subunits while
Mtb promoted only the expression of EBI3 subunit. These
findings suggested that signalling pathways regulating the
expression of IL-12 and IL-27 mediated by the IRF-3/IFN-
β axis are not operative in Mtb-infected monocytes. Indeed,
evidences indicating the involvement of both NF-κB and
IRF-3 in the expression of IL-12p35 have been provided by
Goriely and collaborators [18, 19]. In addition, our previous
study showed that the expression of IL-27p28 subunit was
induced by IFN-β alone or during LPS-induced maturation
of DC in a type I IFN-dependent manner through IRF-
1 activation [12]. Therefore, we sought to investigate the
expression of IFN-β and the related IRF-3 activation in
monocytes challenged with Mtb (Figure 3). IRF-3 is a
transcription factor present in the cytoplasm in a latent form,
which is activated by two kinases known as IKK-ε and TBK-
1 at the level of specific serine residues (Ser385 and Ser386)
present at the C-terminal [20]. In contrast with previous data
showing the ability of Mtb to promote IFN-β expression in
human DC via NF-κB and IRF-3 activation [13], neither
IFN-β nor IRF-3 induction was observed in monocytes
infected with Mtb in spite of a strong NF-κB binding activity
to kB sequences within IFN-β promoter (Figure 3). In
particular, to investigate IRF-3 activation, immunoblots were
performed with whole cell extracts prepared at different time
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Figure 3: Analysis of IFN-β gene regulation in Mtb-infected or LPS-treated human monocytes. (a) Total cell extracts were prepared at
different times following infection with Mtb or LPS treatment. Whole cell extracts (30 μg) were analyzed on an SDS-7% PAGE gel and
subjected to immunoblot analysis with anti-IRF-3 antibody to detect the phosphorylated IRF-3 isoform (IRF-3P; upper panel). The total
content of IRF-3 was evaluated as an internal loading control (IRF-3C; lower panel). The results shown are from one of three experiments
performed with cell extracts from different monocyte cultures that yielded similar results. (b) Nuclear extracts were prepared from Mtb-
infected at different time points or from cells treated for 1 hr with LPS. Five μg of nuclear proteins were subjected to EMSA analysis using as
oligonucleotide the κB-IFN-β sequence. Supershift assays were performed after incubation with anti-p65 Abs as indicated (ss). (c) RNA was
extracted from monocytes infected with Mtb (MOI= 1) or treated with LPS (1 μg/ml) for 8 hr. Real-time reverse transcription-polymerase
chain reaction was performed to measure the expression of IFN-β. The results are shown as a ratio to the GAPDH level and represent the
mean± SE of triplicate values. The results shown are from one out of three experiments performed with different donors that yielded similar
results.
points following infection of monocytes with Mtb or after
3 hr of LPS treatment (Figure 3(a)). To study whether Mtb
infection was able to activate NF-κB complex, monocytes
were infected with Mtb for 1 or 3 hr or treated with LPS
for 1 hr. NF-κB DNA binding was detected 3 hr after Mtb
infection and 1 hr after LPS treatment. We confirmed the
activation of NF-κB by supershift experiments using Abs
raised against the p65 subunit (Figure 3(b)). In addition,
the expression of IFN-β was investigated by real-time RT-
PCR performed on mRNA extracted from Mtb-infected
or LPS-treated monocytes (Figure 3(c)). While LPS-treated
monocytes expressed IFN-β mRNA, Mtb failed to stimulate
IFN-β transcription at 8 hr after infection (Figure 3(c)) and
at later time points (data not shown). Collectively, these
data showed that although monocytes possess the machinery
to activate IRF-3 in response to LPS (Figure 3), Mtb does
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Figure 4: Regulation of IL-23 expression by MAPK in Mtb-infected human monocytes. Monocytes were pretreated or not with p38
(SB203580) or ERK (PD98059) inhibitors for 30 min and afterwards were infected with Mtb as indicated. (a) After 8 hr, RNA was extracted
and real-time RT-PCR was performed to measure the expression of TNF-α and IL-23p19 subunit transcripts. The results shown are from
one out of three experiments performed with different donors that yielded similar results. (b) After 24 hr, the cell culture supernatants
were collected, and the production of TNF-α and IL-23 was measured by CBA or ELISA assay. The results represent the mean± SE of four
independent experiments.
not trigger such pathways and, therefore, does not elicit
the expression of IL-27 and IL-12p70. The TLR-4-mediated
activation of IRF-3, occurring in Mtb-infected DC, seems
to be impaired in monocytes through a mechanism not yet
identified. We can also envisage that Mtb triggers different
receptors on monocytes and DC leading to the activation of
distinct intracellular pathways and, in turn, to the secretion
of specific cytokine profiles.
3.3. Regulation of TNF-α and IL-23 Expression via MAPK in
Mtb-Infected Monocytes. Next, we explored other possible
pathways activated in infected monocytes, which could
account for the production of proinflammatory and regula-
tory cytokines. In particular, we focused on MAPK signalling
that has been described to be involved in the production
of inflammatory cytokines (such as TNF-α, IL-6, and IL-
12p40) and therefore considered important for the initiation
of an effective immune response against Mtb [14, 21–24].
Having found that Mtb induced rapidly both ERK phos-
phorylation and p38 phosphorylation [9], we investigated
the involvement of these pathways on IL-23 expression
given its key role in controlling the inflammatory response
directed against Mtb [14, 25]. As control, we analyzed the
effects induced by the addition of these MAPK inhibitors
on the Mtb-induced expression of TNF-α, which has been
previously demonstrated to be regulated by MAPK [22, 26].
Total RNA was extracted in monocyte cultures pretreated
for 30 min with MAPK inhibitors and afterward infected
with Mtb for additional 8 hr. We observed that p38 was
likely involved in Mtb-induced IL-23 and TNF-α expression
since a strong reduction of transcripts coding for TNF-α and
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IL-23p19 subunit was observed in Mtb-stimulated cultures
pretreated with SB203580. On the contrary, the Mtb-
stimulated expression of IL-23p19 was slightly reinforced
while that of TNF-α was only partially reduced by the Erk
inhibitor PD98059 (Figure 4(a)). On the other hand, the
release of TNF-α and IL-23 was reduced when monocytes
were stimulated with Mtb for 24 hr in presence of MAPK
pharmacological inhibitors (Figure 4(b)). Taken together
these results indicate that Mtb utilizes the MAPK signalling
to promote the expression of the regulatory cytokine IL-23,
which is in turn involved in the fine regulation of Th1/Th17
balance [16].
4. Conclusions
The importance of type-1 cytokines (IL-12, IL-23, and
IFN-γ) in the regulation of innate and adaptive immunity
against different intracellular pathogens, including Mtb,
has been largely demonstrated both in animal models as
well as in individuals with deficiencies in type-1 cytokine
signalling pathways, which have an enhanced susceptibility to
environmental mycobacteria or to the vaccine strain BCG [3,
14, 27]. The emerging picture from these findings indicates
that the interplay between Mtb and phagocytes is crucial for
the final outcome of Mtb infection.
Within this scenario, the role of monocytes has been
underestimated since the majority of the analysis on the
effect induced by Mtb infection in phagocytes has been
performed in macrophages and DC. In this study, we have
characterized the signalling pathways and the expression
of regulatory and proinflammatory cytokines in human
primary monocytes infected by Mtb. Interestingly, a selec-
tive expression of cytokines known to be involved in the
establishment and maintenance of an inflammatory state was
observed. Indeed, the simultaneous release of IL-23, IL-6,
IL-1-β, and TNF-α and the lack of IL-12, IFN-β, and IL-27
production from infected monocytes, likely recruited in the
lung, might impact on both innate and adaptive immune
response directed against Mtb. It has been shown that IL-
12 family cytokines are involved in the autocrine/paracrine
regulation of antimycobacterial activity of macrophages
[28, 29]. Indeed, the treatment with IL-12 and a soluble
receptor for IL-27 during infection reduced the growth of
bacteria recovered from macrophages. Moreover, IL-12 and
IL-27 balance influenced also the profile of proinflammatory
cytokines and chemokines produced by macrophages. In
particular, the neutralization of IL-27 by soluble receptor
has been shown to augment the levels of TNF-α and IFN-γ
during early infection and may allow macrophages to better
combat Mtb at a critical time. Based on these evidences, we
can envisage that the absence of IL-27 production from Mtb-
infected monocytes could lead to a more efficient elimination
of mycobacteria, which is crucial for the containment of the
infection.
In addition to the modulation of antimicrobial activity,
the cytokines released by Mtb-infected monocytes may also
influence the induction of T-cell immunity acting on the
balance between Th1/Th17 memory responses. Indeed, IL-
12p70 is required for the optimal IFN-γ T-cell response,
which is crucial for control of Mtb growth while IL-23
can induce IFN-γ responses in the lung if IL-12 is not
present. However, the major property of IL-23 is the ability
to sustain the function of IL-17-producing γδ T [30] and
the Th17 expansion [15, 16], which are, respectively, essential
component of the early and late protective immune response
directed against intracellular pathogens within the lung,
respectively.
Although the role of Th17 in the immune response to
Mtb is still controversial [31], future vaccine strategies have
to consider also a correct stimulation of monocytes, which
participate to the immune response against Mtb not only
by supplying the infected lung tissues with precursors of
macrophages and DC, but also providing a cytokine milieu
favouring the IL-17 response.
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